Insider Buying: Amrize (NYSE:AMRZ) CFO Purchases $142,140.00 in Stock

Amrize Ltd (NYSE:AMRZ) CFO Baris Oran acquired 3,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was purchased at an average price of $47.38 per share, with a total value of $142,140.00. Following the transaction, the chief financial officer owned 3,000 shares of the company’s stock, valued at approximately $142,140. This trade represents a ? increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Amrize Trading Down 0.2%

AMRZ stock opened at $46.66 on Friday. Amrize Ltd has a 52-week low of $46.03 and a 52-week high of $65.94. The company has a quick ratio of 0.89, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The firm has a market cap of $25.81 billion, a P/E ratio of 21.50, a PEG ratio of 1.00 and a beta of 0.11. The company’s 50-day simple moving average is $51.21 and its 200-day simple moving average is $54.47.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The business had revenue of $3.50 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. As a group, equities analysts forecast that Amrize Ltd will post 2.72 EPS for the current fiscal year.

Amrize Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is presently 20.28%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on AMRZ. Oppenheimer decreased their target price on Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 21st. Morgan Stanley set a $63.00 price target on shares of Amrize and gave the stock an “overweight” rating in a report on Monday, June 22nd. Truist Financial restated a “hold” rating and set a $48.00 price objective (down from $65.00) on shares of Amrize in a research report on Tuesday, July 7th. Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research report on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $60.57.

Amrize News Summary

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Multiple insiders bought shares: Executives purchased more than $697,000 of Amrize stock on August 11, including CFO Baris Oran, CTO Roald Brouwer, Stephen S. Clark, Mario Gross and Jaime Hill. The buying may signal that management considers the recent weakness an attractive entry point. Amrize insider buying report
• Positive Sentiment: Stephens maintained a Buy rating on Amrize, reinforcing the view that the building-materials company has longer-term upside potential. Stephens maintains Buy rating
• Positive Sentiment: Amrize declared a quarterly dividend of $0.11 per share, payable August 26 to shareholders of record August 18. The dividend provides modest income support, although the ex-dividend date may contribute to near-term trading volatility.
• Neutral Sentiment: Jefferies initiated coverage with a Hold rating, giving investors a cautious view that offsets some of the optimism from Stephens and the insider purchases. Jefferies gives Amrize a Hold rating
• Negative Sentiment: Amrize’s latest quarterly earnings missed expectations, with EPS of $0.88 versus the $0.92 consensus estimate. Revenue was $3.50 billion, while analysts expect full-year EPS of $2.72, keeping earnings execution a concern.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC purchased a new position in Amrize in the 2nd quarter valued at $265,000. M&T Bank Corp acquired a new stake in Amrize during the 2nd quarter worth $205,000. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Amrize during the second quarter worth $3,870,000. Gabelli Funds LLC purchased a new stake in shares of Amrize during the second quarter worth $1,083,000. Finally, AXA S.A. purchased a new stake in shares of Amrize during the second quarter worth $1,065,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.